List of Tables
Table 1: Symptoms of HNC, 2017 13
Table 2: Symptoms of HNC Metastasis, 2017 13
Table 3: Common Mutations in HNC Metastasis, 2017 19
Table 4: TNM Classification of Lip, Oral Cavity, and Oropharyngeal Cancers, 2017 23
Table 5: TNM Classification of the Larynx, 2017 24
Table 6: TNM Classification of the Hypopharynx, 2017 26
Table 7: TNM Classification of Salivary Gland Cancers, 2017 27
Table 8: TNM Classification of Nasopharyngeal Cancers, 2017 28
Table 9: Stage Grouping for HNC (Excluding Nasopharyngeal and Thyroid Cancer), 2017 29
Table 10: Stage Grouping for Nasopharyngeal Cancer, 2017 29
Table 11: HNC Therapeutics Market, Global, Licensing Deals Valued Above $10m, 2006–2017 114
Table 12: HNC Therapeutics Market, Global, Co-development Deals Valued Above $10m, 2006–2017 120
Table 13: HNC Therapeutics Market, Global, All Pipeline Products, Discovery, 2017 121
Table 14: HNC Therapeutics Market, Global, All Pipeline Products, Preclinical, 2016 122
Table 15: HNC Therapeutics Market, Global, All Pipeline Products, IND/CTA-filed, 2017 125
Table 16: HNC Therapeutics Market, Global, All Pipeline Products, Phase I, 2017 126
Table 17: HNC Therapeutics Market, Global, All Pipeline Products, Phase II, 2017 130
Table 18: HNC Therapeutics Market, Global, All Pipeline Products, Phase III, 2017 133
Table 19: HNC Therapeutics Market, APAC, Market Forecast, 2016–2023 134
Table 20: HNC Therapeutics Market, India, Market Forecast, 2016–2023 134
Table 21: HNC Therapeutics Market, China, Market Forecast, 2016–2023 134
Table 22: HNC Therapeutics Market, Australia, Market Forecast, 2016–2023 135
Table 23: HNC Therapeutics Market, South Korea, Market Forecast, 2016–2023 135
Table 24: HNC Therapeutics Market, Japan, Market Forecast, 2016–2023 136